Scott Rivkees: Florida Surgeon General, Biography, Career & Key Facts
Scott A. Rivkees, MD, is a name that appears in two very different arenas: the highly specialized world of pediatric endocrinology research and the high-pressure arena of state-level public health leadership. As a physician-scientist, he spent decades studying how hormones, melatonin, and the developing brain shape a child's growth and health. As Florida's State Surgeon General, he became the face of a state health department navigating one of the most disruptive public health crises in modern memory.
That combination — a laboratory researcher who suddenly found himself answering pandemic questions in press conferences — makes his career unusual even among physician-executives. Understanding Scott Rivkees means looking at both halves of his professional life: the academic who published hundreds of studies on thyroid disease and circadian biology, and the administrator who oversaw Florida's Department of Health from 2019 to 2021.
Early Life, Education, and Medical Training
Rivkees built his medical foundation in the Midwest. He earned his undergraduate and medical degrees at the University of Wisconsin, then moved east for specialty training in Boston at Harvard-affiliated teaching hospitals, where he completed a residency in pediatrics and a fellowship in pediatric endocrinology. That path — from a broad pediatric residency into a narrow subspecialty — is typical of physician-scientists who eventually split their time between patients and laboratories.
What set him apart early was an interest in the biology of development itself. Rather than focusing only on clinical treatment, he gravitated toward questions about how the infant brain and endocrine system mature, and how disruptions in that process produce lifelong consequences. That curiosity shaped nearly everything he did afterward.
From Wisconsin to Boston: Formative Training
Wisconsin gave Rivkees a grounding in general medicine and a strong basic-science education. Boston gave him exposure to some of the most competitive clinical and research environments in the country, where pediatric endocrinology was evolving rapidly thanks to advances in molecular biology, genetics, and hormone assays.
During those years, pediatric endocrinology was shifting from a largely descriptive field into one driven by receptor biology and gene regulation. Trainees who could move comfortably between a patient's bedside and a bench experiment were in demand, and Rivkees fit that mold.
Rising Through Academic Medicine
Rivkees spent a substantial portion of his career at Yale School of Medicine, where he served as a professor of pediatrics, led the pediatric endocrinology division, and directed the Yale Child Health Research Center. In those roles he combined laboratory investigation with mentoring, grant funding, and the recruitment of junior faculty.
He later moved to the University of Florida College of Medicine, where he chaired the Department of Pediatrics and served as physician-in-chief at UF Health Shands Children's Hospital. That role required a different skill set — budget management, faculty development, hospital operations — and it positioned him for the public-sector appointment that would eventually make him a household name in Florida.
Research Contributions in Pediatric Endocrinology
Rivkees's scientific output spans several distinct areas, but two themes dominate: the neurobiology of circadian rhythms and the clinical management of thyroid disease in children. His work has appeared in peer-reviewed journals including Endocrinology, the Journal of Clinical Endocrinology & Metabolism, and Pediatric Research, and it has been supported by National Institutes of Health funding.
Beyond publications, his research influenced clinical practice guidelines. When laboratory findings translate into changes in how physicians prescribe a drug or screen a newborn, that is a meaningful measure of impact — and in the thyroid field, that is precisely what happened.
Melatonin, Circadian Rhythms, and Early Brain Development
One of Rivkees's most cited lines of research explored melatonin receptors and the suprachiasmatic nucleus, the small cluster of brain cells that governs the body's internal clock. His work helped clarify how the circadian system develops in fetal and newborn mammals, and how maternal melatonin signals may influence that process before an infant's own clock matures.
That research mattered well beyond the laboratory. Understanding when and how a newborn's sleep-wake cycle develops has implications for neonatal intensive care, for feeding schedules, and for how clinicians think about premature birth. Related work in his lab examined adenosine, caffeine, and brain development, contributing to a broader conversation about stimulant exposure during critical developmental windows.
Thyroid Disorders in Children
Rivkees became widely recognized for his work on pediatric hyperthyroidism, particularly Graves' disease. He studied treatment strategies involving antithyroid medications, radioactive iodine, and surgery, and he published influential analyses of the risks associated with propylthiouracil — including reports of severe liver injury in children that contributed to heightened caution and regulatory attention around the drug's pediatric use.
He also worked on congenital hypothyroidism and newborn screening, the public health system that catches thyroid deficiencies early enough to prevent intellectual disability. Together, these contributions represent a bridge between bench science and population-level prevention.
Florida State Surgeon General and Public Health Leadership
In June 2019, Florida Governor Ron DeSantis appointed Rivkees as State Surgeon General and Secretary of the Florida Department of Health. The role combined medical advisory duties with the day-to-day management of a sprawling agency responsible for disease surveillance, environmental health, licensure, and county health departments across the state.
His early months in office focused on issues that rarely grab national headlines: a hepatitis A outbreak, the opioid epidemic, water quality concerns such as red tide, and maternal and infant health. Those priorities reflected the traditional scope of a state health department, and they were largely overshadowed by what came next.
Leading Through the COVID-19 Pandemic
When COVID-19 arrived in Florida in early 2020, Rivkees became the state's chief medical voice on the pandemic. His department managed testing capacity, built and maintained a public data dashboard, and coordinated with hospitals and county health officials. Under his tenure, Florida prioritized vaccinating older adults during the initial rollout — a strategy that drew national attention for its focus on a high-risk population.
His tenure was also marked by friction. Public health experts and some legislators criticized the department for limited transparency around data, for the relatively low public profile of the surgeon general compared with counterparts in other states, and for guidance that sometimes appeared to align with political messaging out of the governor's office. Rivkees, for his part, consistently framed his decisions as grounded in available evidence.
The balancing act was genuine: a scientist trained to speak in probabilities and caveats, working inside a political environment that rewards certainty. Few public health officials emerge from such a stretch without criticism, and Rivkees was no exception.
Departure and Return to Academic Medicine
Rivkees stepped down from the surgeon general post in September 2021, when DeSantis named Dr. Joseph Ladapo as his successor. The transition came as Florida's pandemic policies — including opposition to mask mandates and vaccine requirements — were becoming increasingly polarized nationally.
After leaving Tallahassee, Rivkees returned to academic medicine at the University of Florida, where he resumed clinical, teaching, and scholarly work in pediatrics. The move was a return to the environment where his career began: research questions, resident education, and patient care rather than press briefings.
For those tracking the intersection of science and governance, Scott Rivkees remains an instructive figure — a reminder that the same person can publish receptor biology studies and testify before a legislative committee in the same decade. His career continues to unfold in academic medicine, where the questions that first drew him into endocrinology still have unanswered corners. Readers interested in pediatric thyroid care or public health leadership would do well to follow where his work goes next.